These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24495535)

  • 1. Impact of methodology on estrogens' effects on cerebral ischemia in rats: an updated meta-analysis.
    Ström JO; Ingberg E
    BMC Neurosci; 2014 Feb; 15():22. PubMed ID: 24495535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage.
    Strom JO; Theodorsson E; Holm L; Theodorsson A
    BMC Neurosci; 2010 Mar; 11():39. PubMed ID: 20236508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia.
    Strom JO; Theodorsson A; Theodorsson E
    Int J Mol Sci; 2011; 12(3):1533-62. PubMed ID: 21673906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis.
    Strom JO; Theodorsson A; Theodorsson E
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1359-72. PubMed ID: 19458604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke.
    McCullough LD; Alkayed NJ; Traystman RJ; Williams MJ; Hurn PD
    Stroke; 2001 Mar; 32(3):796-802. PubMed ID: 11239204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke.
    Carpenter RS; Iwuchukwu I; Hinkson CL; Reitz S; Lee W; Kukino A; Zhang A; Pike MM; Ardelt AA
    Brain Res; 2016 May; 1639():200-13. PubMed ID: 26995494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of estrogens and related compounds in the treatment of damage from cerebral ischemia.
    Yang SH; Liu R; Wu SS; Simpkins JW
    Ann N Y Acad Sci; 2003 Dec; 1007():101-7. PubMed ID: 14993044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences and the effects of synthetic exogenous and non-synthetic estrogens in focal cerebral ischemia.
    Vergouwen MD; Anderson RE; Meyer FB
    Brain Res; 2000 Sep; 878(1-2):88-97. PubMed ID: 10996139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and experimental ischemic stroke: a systematic review.
    Gibson CL; Gray LJ; Murphy SP; Bath PM
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1103-13. PubMed ID: 16437060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
    Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
    J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia.
    Liu R; Wang X; Liu Q; Yang SH; Simpkins JW
    Neurosci Lett; 2007 Mar; 415(3):237-41. PubMed ID: 17331646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen, neuroprotection and neurogenesis after ischemic stroke.
    Shao B; Cheng Y; Jin K
    Curr Drug Targets; 2012 Feb; 13(2):188-98. PubMed ID: 22204318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Window of opportunity: estrogen as a treatment for ischemic stroke.
    Liu R; Yang SH
    Brain Res; 2013 Jun; 1514():83-90. PubMed ID: 23340160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and ischemic neuroprotection: an integrated view.
    McCullough LD; Hurn PD
    Trends Endocrinol Metab; 2003 Jul; 14(5):228-35. PubMed ID: 12826329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.
    Suzuki S; Brown CM; Dela Cruz CD; Yang E; Bridwell DA; Wise PM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6013-8. PubMed ID: 17389368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.
    Inagaki T; Etgen AM
    Steroids; 2013 Jun; 78(6):597-606. PubMed ID: 23385013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals.
    Rusa R; Alkayed NJ; Crain BJ; Traystman RJ; Kimes AS; London ED; Klaus JA; Hurn PD
    Stroke; 1999 Aug; 30(8):1665-70. PubMed ID: 10436119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.